Literature DB >> 6544357

Clinical and laboratory findings in untreated patients with Hodgkin's disease with special reference to age.

C Wedelin, M Björkholm, B Johansson, H Mellstedt.   

Abstract

During a 6-yr period 258 adult patients (greater than or equal to 15 yr) with biopsy verified Hodgkin's disease (HD) were reported to the Stockholm-Gotland Oncologic Center. In 57 elderly patients (mean age 74 yr) the diagnosis was established shortly before death or at autopsy. One hundred and eighty-two of remaining 201 patients (118 men and 64 women, mean age 47 yr) were investigated. They were evenly distributed in stages I-IV and 43% had B symptoms. NS, 38% and MC, 38% were the most common histological subtypes in contrast to LP, 14% and LD, 10%. Stage II disease and NS histopathology dominated among patients below 50 yr. Patients with hilar/mediastinal lymphomas were often young and had NS histopathology with B symptoms. The diagnosis was established within 3 months after the first symptoms in 52% while 15% had symptoms for more than one year. Eleven patients reported a previous malignancy which is similar to the expected number of 13.8. The results support the concept that in unselected patient series HD seems to be at least as common among elderly as in young people. In the investigated series advanced disease and MC and LD histopathology did not dominate among patients above 50 yr which has been reported previously.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6544357     DOI: 10.1007/bf02935323

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  38 in total

1.  Alcohol pain in Hodgkin's disease.

Authors:  K Atkinson; D E Austin; T J McElwain; M J Peckham
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

2.  Combination chemotherapy in the treatment of advanced Hodgkin's disease.

Authors:  V T Devita; A A Serpick; P P Carbone
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

3.  Hodgkin's disease in Sheffield (1971--76) (with computer analysis of variables).

Authors:  B W Hancock; M Aitken; J F Martin; I R Dunsmore; C M Ross; I Carr; I G Emmanuel
Journal:  Clin Oncol       Date:  1979-12

4.  Immune status of untreated patients with Hodgkin's disease and prognosis.

Authors:  M Björkholm; C Wedelin; G Holm; S Ogenstad; B Johansson; H Mellstedt
Journal:  Cancer Treat Rep       Date:  1982-04

5.  Hodgkin's disease: one entity or two?

Authors:  D W Smithers
Journal:  Lancet       Date:  1970-12-19       Impact factor: 79.321

6.  Histology, age and sex distribution, and pathologic correlations of Hodgkin's disease: a study of 184 cases observed in Rome, Italy.

Authors:  C D Baroni; F Malchiodi
Journal:  Cancer       Date:  1980-04-01       Impact factor: 6.860

7.  Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients.

Authors:  R S Brown; H A Haynes; H T Foley; H A Godwin; C W Berard; P P Carbone
Journal:  Ann Intern Med       Date:  1967-08       Impact factor: 25.391

8.  Prognostic factors in Hodgkin's disease. I. Analysis of histopathology, stage distribution and results of therapy.

Authors:  M Björkholm; G Holm; H Mellstedt; B Johansson; J Askergren; G Söderberg
Journal:  Scand J Haematol       Date:  1977-11

9.  Cyclic autoimmune hemolytic anemia as a presenting manifestation of splenic Hodgkin's disease.

Authors:  M Björkholm; G Holm; K Merk
Journal:  Cancer       Date:  1982-04-15       Impact factor: 6.860

10.  Prognostic factors in Hodgkin's disease with special reference to age.

Authors:  C Wedelin; M Björkholm; P Biberfeld; G Holm; B Johansson; H Mellstedt
Journal:  Cancer       Date:  1984-03-01       Impact factor: 6.860

View more
  2 in total

1.  Comprehensive epidemiological and clinicopathological survey of Hodgkin's disease in Hungary.

Authors:  E Berényi; G Szegedi; K Szabó; L István; G Radványi; S Berkessy; M Zöllei; G Varga; Z Nemes; G Kelényi
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Increased luminol-enhanced chemiluminescence of blood monocytes and granulocytes in Hodgkin's disease.

Authors:  O Tullgren; R Giscombe; G Holm; B Johansson; H Mellstedt; M Björkholm
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.